Abstract:Pharmaceuticals are of concern to our planet and health as they can accumulate in the environment. The impact of these biologically active compounds on ecosystems is hard to predict, and information on their biodegradation is necessary to establish sound risk assessment. Microbial communities are promising candidates for the biodegradation of pharmaceuticals such as ibuprofen, but little is known yet about their degradation capacity of multiple micropollutants at higher concentrations (100 mg/L). In this work, microbial communities were cultivated in lab-scale membrane bioreactors (MBRs) exposed to increasing concentrations of a mixture of six micropollutants (ibuprofen, diclofenac, enalapril, caffeine, atenolol, paracetamol). Key players of biodegradation were identified using a combinatorial approach of 16S rRNA sequencing and analytics. Microbial community structure changed with increasing pharmaceutical intake (from 1 to 100 mg/L) and reached a steady-state during incubation for 7 weeks on 100 mg/L. HPLC analysis revealed a fluctuating but significant degradation (30-100%) of five pollutants (caffeine, paracetamol, ibuprofen, atenolol, enalapril) by an established and stable microbial community mainly composed of Achromobacter, Cupriavidus, Pseudomonas and Leucobacter. By using the microbial community from MBR1 as inoculum for further batch culture experiments on single micropollutants (400 mg/L substrate, respectively), different active microbial consortia were obtained for each single micropollutant. Microbial genera potentially responsible for degradation of the respective micropollutant were identified, i.e. Pseudomonas sp. and Sphingobacterium sp. for ibuprofen, caffeine and paracetamol, Sphingomonas sp. for atenolol and Klebsiella sp. for enalapril. Our study demonstrates the feasibility of cultivating stable microbial communities capable of degrading simultaneously a mixture of highly concentrated pharmaceuticals in lab-scale MBRs and the identification of microbial genera potentially responsible for the degradation of specific pollutants. KEY POINTS: • Multiple pharmaceuticals were removed by stable microbial communities. • Microbial key players of five main pharmaceuticals were identified.

Unraveling the potential of a combined nitritation-anammox biomass towards the biodegradation of pharmaceutically active compounds

Simultaneous Ammonia and Nitrate Removal in an Airlift Reactor Using Poly(butylene Succinate) As Carbon Source and Biofilm Carrier.

How efficiently does a metabolically enhanced system with denitrifying anaerobic methane oxidizing microorganisms remove antibiotics?

Nitrogen Removal Performance of Anammox Process and Toxic Mechanism of Pharmaceutical Wastewater

Feasibility of Partial-Denitrification/anammox for Pharmaceutical Wastewater Treatment in a Hybrid Biofilm Reactor

Application of Bioaugmentation to Improve Pharmaceutical Wastewater Treatment Efficiency

Microbial community and performance of a partial nitritation/anammox sequencing batch reactor treating textile wastewater

Effect of concentration and hydraulic reaction time on the removal of pharmaceutical compounds in a membrane bioreactor inoculated with activated sludge

Combined use of strictly anaerobic MBBR and aerobic MBR for municipal wastewater treatment and removal of pharmaceuticals

Optimizing intermittent micro-aeration as a strategy for enhancing aniline anaerobic biodegradation: kinetic, ecotoxicity, and microbial community dynamics analyses

Simultaneous Removal and Evaluation of Organic Substrates and NH3-N by a Novel Combined Process in Treating Chemical Synthesis-Based Pharmaceutical Wastewater

Total and Metabolically Active Microbial Community of Aerobic Granular Sludge Systems Operated in Sequential Batch Reactors: Effect of Pharmaceutical Compounds

Analyzing microbial communities and their biodegradation of multiple pharmaceuticals in membrane bioreactors

Synergistic Exposure of Return-Sludge to Anaerobic Starvation, Sulfide, and Free Ammonia to Suppress Nitrite Oxidizing Bacteria

Nitrogen Removal Efficiency for Pharmaceutical Wastewater with a Single-Stage Anaerobic Ammonium Oxidation Process

A novel simultaneous short-course nitrification, denitrification and fermentation process: bio-enhanced phenol degradation and denitrification in a single reactor

Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation.

Enhanced nitrogen removal from pharmaceutical wastewater using SBA-ANAMMOX process

Tracing pharmaceuticals in a municipal plant for integrated wastewater and organic solid waste treatment

Biotic and abiotic removal of acetaminophen during sidestream partial nitritation processes: Underlying mechanisms and transformation pathways

Enhanced Antibiotic Removal in a Nitrifying Sludge System by Ammonia-Oxidizing Bacteria and Heterotrophs